Source comparison
CJC-1295 no DAC vs GHRP-6 Acetate — Which is Better?
CJC-1295 without DAC doesn't extend growth hormone half-life. It amplifies each natural pulse your pituitary already produces, then clears within 30 minutes. GHRP-6 Acetate works through a completely different mechanism: it binds directly to ghrelin receptors
This comparison does not assign a generated winner or score.
- CJC-1295 without DAC doesn't extend growth hormone half-life. It amplifies each natural pulse your pituitary already produces, then clears within 30 minutes. GHRP-6 Acetate works through a completely different mechanism: it binds directly to ghrelin receptors in the hypothalamus and triggers an immediate, intense GH spike. But it also activates appetite signaling that most researchers didn't account for in their protocols. One peptide extends what your body is already doing. The other forces a response whether your pituitary is cycling or not.
- Our team has guided hundreds of research protocols involving both compounds. The confusion between these two peptides isn't about efficacy. It's about mechanism fit. Most comparison guides treat them as interchangeable GH secretagogues, but the receptor pathways, clearance rates, and downstream metabolic effects are fundamentally different.
- What's the difference between CJC-1295 no DAC and GHRP-6 Acetate?
- CJC-1295 no DAC (also called modified GRF 1-29) is a growth hormone-releasing hormone (GHRH) analogue that amplifies endogenous GH pulses without extending plasma half-life. Clearance occurs within 30 minutes. GHRP-6 Acetate is a growth hormone-releasing peptide (GHRP) that acts as a ghrelin receptor agonist, triggering immediate GH release independent of natural pulsatile cycles. CJC-1295 no DAC works synergistically with your body's existing GHRH rhythm; GHRP-6 overrides it entirely and adds appetite stimulation as a secondary effect.
- The fundamental mistake most researchers make is assuming these compounds do the same thing at different potencies. They don't. CJC-1295 no DAC requires an intact pituitary axis. If your natural GH pulse amplitude is suppressed (chronic sleep deprivation, hypothalamic dysfunction), the peptide has nothing to amplify. GHRP-6 bypasses that limitation entirely by directly stimulating ghrelin receptors, which trigger GH secretion even when endogenous GHRH signaling is compromised. This article covers the receptor-level mechanisms, the evidence for stacking vs monotherapy, what happens when dosing timing misaligns with circadian GH rhythms, and which peptide fits specific research applications.